In this article, NSF International goes into detail about what the potential ramifications of Brexit may be on the regulatory landscape in pharma.
Brexit rethink
The only thing that is certain following the UK’s momentous decision to leave the European Union (EU), so called Brexit, is that the pharmaceutical industry, as all others, is facing at least two years of unprecedented uncertainty.